Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 1923
TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223001BDBM223001(US9320732, 3 | US10034939, Example 3 | US9789094, ...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 347312BDBM347312(N-(3-Bromo-4-fluorophenyl)-N′-hydroxy-4-({3-...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223009BDBM223009(US9320732, 11 | US10034939, Example 11 | US9789094...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223010BDBM223010(US9320732, 12 | US10034939, Example 12 | US9789094...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223007BDBM223007(US9320732, 9 | US10034939, Example 9 | US9789094, ...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223008BDBM223008(US9320732, 10 | US10034939, Example 10 | US9789094...)
Affinity DataIC50: 100nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 222999BDBM222999(US9320732, 1 | US10034864, Example 1 | US9789094, ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223000BDBM223000(US9320732, 2 | US10034939, Example 2 | US9789094, ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 347315BDBM347315(4-({3-[(Aminosulfonyl)amino]propyl}amino)-N-(3-chl...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223006BDBM223006(US9320732, 8 | US10034939, Example 8 | US9789094, ...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 50233431BDBM50233431(CHEMBL3979473 | US9789094, 5 | US20240173303, Exam...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 347314BDBM347314(N-(3-Chloro-4-fluorophenyl)-N′-hydroxy-4-({2...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223013BDBM223013(US9320732, 15 | US10034939, Example 15 | US9789094...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223014BDBM223014(US9320732, 16 | US10034939, Example 16 | US9789094...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223012BDBM223012(US9320732, 14 | US10034864, Example 14 | US9789094...)
Affinity DataIC50: 200nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223017BDBM223017(US9320732, 19 | US10034939, Example 19 | US9789094...)
Affinity DataIC50: 500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223018BDBM223018(US9320732, 20 | US9320732, 21 | US10034939, Exampl...)
Affinity DataIC50: 500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223015BDBM223015(US9320732, 17 | US10034939, Example 17 | US9789094...)
Affinity DataIC50: 500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223011BDBM223011(US9320732, 13 | US10034939, Example 13 | US9789094...)
Affinity DataIC50: 500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 223016BDBM223016(US9320732, 18 | US10034939, Example 18 | US9789094...)
Affinity DataIC50: 750nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Incyte Holdings

US Patent
LigandChemical structure of BindingDB Monomer ID 279193BDBM279193(4-({2-[(Aminosulfonyl)amino]ethyl}amino)-N-[(4-chl...)
Affinity DataIC50: 750nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent